0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 161-180 of 496 Articles
Editor's Correspondence | 
Roy C. Ziegelstein, MD, MACP
JAMA Intern Med. 2013;173(8):713-714. doi:10.1001/jamainternmed.2013.3785.

Research Letters |  FREE
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.
JAMA Intern Med. 2013;173(8):704-706. doi:10.1001/jamainternmed.2013.2807.
Includes: Supplemental Content

Original Investigation |  FREE
Nick Daneman, MD, MSc; Andrea Gruneir, PhD; Susan E. Bronskill, PhD; et al.
JAMA Intern Med. 2013;173(8):673-682. doi:10.1001/jamainternmed.2013.3029.

Invited Commentary | 
Carmel M. Hughes, PhD; Michael M. Tunney, PhD
JAMA Intern Med. 2013;173(8):682-683. doi:10.1001/jamainternmed.2013.4077.

Original Investigation |  FREE
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Intern Med. 2013;173(7):534-539. doi:10.1001/jamainternmed.2013.2720.
Includes: Supplemental Content

Editor's Correspondence | 
Joseph V. Rodricks, PhD; Michael H. Lumpkin, PhD
JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.2533.

Editor's Correspondence | 
Pieter A. Cohen, MD
JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.3776.

Editor's Correspondence | 
Aaron S. Geller, MD
JAMA Intern Med. 2013;173(7):595-596. doi:10.1001/jamainternmed.2013.3045.

Editor's Correspondence | 
Jane C. Ballantyne, MD, FRCA; Mark D. Sullivan, MD, PhD; Andrew Kolodny, MD
JAMA Intern Med. 2013;173(7):595-596. doi:10.1001/jamainternmed.2013.3207.

Editor's Correspondence | 
J. Simon Bell, PhD
JAMA Intern Med. 2013;173(7):596-597. doi:10.1001/jamainternmed.2013.3280.

Invited Commentary | 
Amy Linsky, MD, MSc; Steven R. Simon, MD, MPH
JAMA Intern Med. 2013;173(7):524-525. doi:10.1001/jamainternmed.2013.4068.

Invited Commentary | 
Belinda Gier, PhD; Peter C. Butler, MD
JAMA Intern Med. 2013;173(7):539-541. doi:10.1001/jamainternmed.2013.3374.

Research Letters |  FREE
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
JAMA Intern Med. 2013;173(7):586-588. doi:10.1001/jamainternmed.2013.2797.
Includes: Supplemental Content

Original Investigation |  FREE
Gregory S. Cooper, MD; Tzuyung D. Kou, PhD; Douglas K. Rex, MD
JAMA Intern Med. 2013;173(7):551-556. doi:10.1001/jamainternmed.2013.2908.

Invited Commentary | 
Karen J. Wernli, PhD; John M. Inadomi, MD
JAMA Intern Med. 2013;173(7):556-558. doi:10.1001/jamainternmed.2013.4071.

Evidence to Practice | 
Lisa Bero, PhD
JAMA Intern Med. 2013;173(7):580-581. doi:10.1001/jamainternmed.2013.4190.

Original Investigation |  FREE
Marcello Maggio, MD, PhD; Andrea Corsonello, MD; Gian Paolo Ceda, MD; et al.
JAMA Intern Med. 2013;173(7):518-523. doi:10.1001/jamainternmed.2013.2851.
Includes: CME

Original Investigation |  FREE
Jason D. Wright, MD; Alfred I. Neugut, MD, PhD; Cande V. Ananth, PhD; et al.
JAMA Intern Med. 2013;173(7):559-568. doi:10.1001/jamainternmed.2013.2921.

Review Article |  FREE
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
JAMA Intern Med. 2013;173(7):496-505. doi:10.1001/jamainternmed.2013.3733.
Includes: Supplemental Content

Research Letters |  FREE
Yuting Zhang, PhD; Shang-Hua Wu, MS; A. Mark Fendrick, MD; et al.
JAMA Intern Med. 2013;173(6):468-470. doi:10.1001/jamainternmed.2013.2509.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA
Viewpoint  | 
Educational Opportunities With Postevent Debriefing
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.